Article Detail

Home > Article Detail
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

Article Contents

    Simultaneous qualitative and quantitative analysis of morroniside and hederacoside D in extract mixture of Cornus officinalis and Stauntonia hexaphylla leaves to improve benign prostatic hyperplasia by HPLC-UV

    Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2020, v.33 no.5, pp.224-231
    https://doi.org/10.5806/AST.2020.33.5.224
    Gao Dan (College of Pharmacy, Chungnam National University)
    Chong Woon Cho (College of Pharmacy, Chungnam National University)
    Le Ba Vinh (College of Pharmacy, Chungnam National University / Institute of Marine Biochemistry (IMBC), Vietnam Academic of Science and Technology (VAST))
    Jin Hyeok Kim (College of Pharmacy, Chungnam National University)
    Kyoung Won Cho (Chong Kun Dang Healthcare)
    Young Ho Kim (College of Pharmacy, Chungnam National University)
    Jong-Seong Kang (College of Pharmacy, Chungnam National University)
    • Downloaded
    • Viewed

    Abstract

    With the improvement in the standard of living and extension of life expectancy, the incidence of prostate diseases has increased yearly, thus becoming a serious disease affecting the health of men. The extract mixture of Cornus officinalis and Stauntonia hexaphylla leaves is a developed functional food formula to improve prostate health. This study developed a simultaneous analytical method of bioactive compounds for quantifying the mixture of Cornus officinalis and S. hexaphylla leaves using high-pressure liquid chromatography-ultraviolet (HPLC–UV). HPLC analytical condition was performed on a Hector C18 column with a mobile phase of 0.1 % formic acid in water (A) and 0.1 % formic acid in acetonitrile (B) under the following gradient conditions: 0-50 min, 12 %-40 % (B) at a flow rate of 1.0 mL/min. Meanwhile, this method was validated properly and successfully used to quantify the bioactive components of morroniside and hederacoside D in 20 sample batches and assess the quality of different ages and seasons of S. hexaphylla leaves. The result showed that the content of morroniside in the extract mixture of Cornus officinalis and S. hexaphylla leaves ranged from 1.38-1.62 mg/g, and the hederacoside D ranged from 28.42-32.02 mg/g, suggesting that this novel analytical method will be suitable for the quality control of the extract mixture to improve benign prostatic hyperplasia.

    keywords
    benign prostatic hyperplasia, HPLC-UV, cornus officinalis, stauntonia hexaphylla, LC-ESI-MS/MS


    Reference

    1

    1. J. Evans, K. R. J. Jethwa, P. Ost, S. Williams, E. D. Kwon, V. J. Lowe and B. J. Davis, Practical Radiation Oncology, 8(8), 28-39 (2018).

    2

    2. F. Malongane, L. J. McGaw and F. N. Mudau, J. Sci. Food Agric., 97(14), 4679-4689 (2017).

    3

    3. C.-H. Tsai, S.-F. Tzeng, S.-C. Hsieh, Y.-C. Yang, Y.-W. Hsiao, M.-H. Tsai and P.-W. Hsiao, Sci. Rep., 7(1), 1-14(2017).

    4

    4. J. Y. Jung, S. S. L. Karunasagara, G. L. Hong, E. J. Koh, K. W. Cho, S. S. Park and K. H. Kim, BioRxiv, 819474(2019) https://doi.org/10.1101/819474.

    5

    5. H. K. Bhakta, C. H. Park, T. Yokozawa, T. Tanaka, H. A. Jung and J. S. Choi, Arch. Pharm. Res., 40(7), 836-853 (2017).

    6

    6. W. Ma, K.-J. Wang, C.-S. Cheng, G.-q. Yan, W.-L. Lu, J.-F. Ge, Y.-X. Cheng and N. Li, J. Ethnopharmacol., 153(3), 840-845 (2014).

    7

    7. X.-S. Ye, J. He, Y.-C. Cheng, L. Zhang, H.-Y. Qiao, X.-G. Pan, J. Zhang, S.-N. Liu, W.-K. Zhang and J.-K. Xu, J. Nat. Prod., 80(12), 3103-3111(2017).

    8

    8. H. Hwangbo, D. H. Kwon, E. O. Choi, M. Y. Kim, K. I. Ahn, S. Y. Ji, J. S. Kim, K.-I. Kim, N.-J. Park, and B. H. Kim, Nutr. Res. Pract. 12(5), 378-386 (2018).

    9

    9. L. B. Vinh, H.-J. Jang, N. V. Phong, K. Cho, S. S. Park, J. S. Kang, Y. H. Kim and S. Y. Yang, Bioorg. Med. Chem. Lett., 29(8), 965-969 (2019).

    10

    10. G.-L. Hong, S.-R. Park, D.-Y. Jung, S. Karunasagara, K. P. Lee, E.-J. Koh, K. Cho, S. S. Park and J.-Y. Jung, J. Ethnopharmacol., 250, 112446 (2020).

    11

    11. W. Du, H. Cai, M. Wang, X. Ding, H. Yang and B. Cai, J. Pharm. Biomed. Anal., 48(1), 194-197(2008).

    12

    12. ICH Guideline. Q2(R1): Validation of Analytical Procedures: Text and Methodology Q2(R1) in ICH Harmonised Tripartite Guideline (2005).

    상단으로 이동

    Analytical Science and Technology